To ascertain if ZNF217’s role as an oncogene in ovarian cancer cells is dependent on its ability to function as a transcription factor, we tested if the ZNF217 DNA binding mutant (ZNF217-H489A) can rescue the phenotypes observed upon ZNF217 knockdown. The gene discussed is ZNF217; the disease is ovarian cancer.